AWSHX
Price
$67.98
Change
-$0.02 (-0.03%)
Updated
Jul 31 closing price
Net Assets
219.02B
RWMAX
Price
$66.72
Change
-$0.02 (-0.03%)
Updated
Jul 31 closing price
Net Assets
219.02B
Interact to see
Advertisement

AWSHX vs RWMAX

AWSHX vs RWMAX Comparison Chart in %
View a ticker or compare two or three
VS
AWSHX vs. RWMAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AWSHX is a Buy and RWMAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AWSHX (219B) and RWMAX (219B) have equal amount of cash in the bank . AWSHX pays higher dividends than RWMAX: AWSHX (1.20) vs RWMAX (0.49). AWSHX was incepted earlier than RWMAX: AWSHX (74 years) vs RWMAX (24 years). RWMAX (1.35) is less costly to investors than AWSHX (0.55). AWSHX (29.00) and RWMAX (29.00) have comparable annual turnover. AWSHX (250) and RWMAX (250) have matching initial minimum investment requirements. AWSHX annual gain was more profitable for investors over the last year : 6.76 vs. RWMAX (5.76). AWSHX return over 5 years is better than : 27.56 vs. RWMAX (23.03).
AWSHXRWMAXAWSHX / RWMAX
Total Expense Ratio0.551.3541%
Annual Report Gross Expense Ratio0.551.3541%
Fund Existence74 years24 years-
Gain YTD4.8904.326113%
Front Load6%N/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets219B219B100%
Annual Yield % from dividends1.200.49244%
Returns for 1 year6.765.76117%
Returns for 3 years27.1123.68114%
Returns for 5 years27.5623.03120%
Returns for 10 years78.7170.86111%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MCYCX15.530.44
+2.92%
NYLI Candriam Emerging Markets Eq Cl C
QKACX56.210.26
+0.46%
Federated Hermes MDT All Cap Core R6
PEQCX44.02-0.03
-0.07%
Putnam Large Cap Value C
MGBRX18.25-0.05
-0.27%
MFS Global Total Return R2
GSAHX20.38-0.11
-0.54%
Goldman Sachs Small Cap Growth Investor